Supplier News

Dec 20, 2017
By Pharmaceutical Technology Editors
MilliporeSigma will collaborate with IPS and G-CON to offer end-to-end, turnkey, modular MAb manufacturing.
Dec 19, 2017
By Pharmaceutical Technology Editors
The company has completed development of a first-generation production process for its chimeric antigen receptor regulatory T cell product portfolio and is selecting a CMO for clinical supply.
Dec 19, 2017
By Pharmaceutical Technology Editors
BioTek Instruments has released a second edition of its BioSpa software that now offers users a simplified but effective interface for kinetic imaging or detection workflows.
Dec 18, 2017
By Pharmaceutical Technology Editors
MJR PharmJet's MicroJet Reactor technology is a continuous process for producing nanoparticles with tightly controlled particle size and particle size distribution.
Dec 14, 2017
By Pharmaceutical Technology Editors
Abzena has entered into a Master Services Agreement with a US biotech company to provide process development and manufacturing services to progress a novel antibody-drug conjugate (ADC) to clinical trials.
Dec 14, 2017
By Pharmaceutical Technology Editors
The Quattroflow QF10k size pump from PSG, a Dover company, has been added to its line of quaternary, four-piston diaphragm pumps.
Dec 13, 2017
By Pharmaceutical Technology Editors
The European Medicines Agency has granted Samsung BioLogics approval to manufacture a monoclonal antibody at the company’s second facility in Songdo, Incheon, South Korea.
Dec 12, 2017
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
SGS has introduced a Sanger sequencing service at its Glasgow, United Kingdom, laboratory to support genetic stability testing and perform identity testing on cell banks, plasmids, and viral seeds/vectors.
Dec 08, 2017
By Pharmaceutical Technology Editors
Gilead Sciences will acquire Cell Design Labs to further cell-therapy research and development efforts.
Dec 08, 2017
By Pharmaceutical Technology Editors
The new 30,000-L, $150-million biologics manufacturing facility in Wuxi, China, quintuples the company’s existing manufacturing capability.
native1_300x100
lorem ipsum